In January this year, a survey by YouGov(1), commissioned by the Welsh NHS Confederation and supported by ABPI and the 1000 Lives Improvement Service of NHS Wales, sought the views of the Welsh public on their health services and treatments. Over one thousand individuals responded to the online...
Following the publication of all the main party manifestos in Wales, there has been widespread support for the commitments to additional funding for innovative medicines. This encouragement has not just been from those of us directly involved in making the case for greater access, but from the wider...
Following negotiations between the General Practitioners Committee (GPC) and NHS Employers (on behalf of the four health departments), agreement with the English, Scottish and Welsh departments on changes to the General Medical Services contract for 2011-12 has been reached.
ABPI Cymru Wales is excited to welcome the distinguished Lord Robert Winston, as he gives our annual lecture at the National Museum of Wales, Cardiff on Tuesday 1 November 2011.
In partnership with the Welsh Medicines Partnership (WMP), ABPI Cymru Wales is organising a Masterclass to improve understanding of the All Wales Medicines Strategy Group (AWMSG) Healthcare Technology Appraisal (HTA) process on 14 July 2011.
ABPI Cymru Wales has published its spring bulletin, keeping you up-to-date with the latest developments.
We are delighted to give you the opportunity to learn more about the way the Healthcare Technology Appraisal (HTA) process is changing in Wales at this Masterclass on Monday 8 October 2012.
Today, the ABPI updated its guidance on guidelines for collection of adverse events. Why is this important and what difference will it make for you?
We are delighted to offer you the opportunity to learn more about how the appraisal process works in Wales, providing a networking opportunity with colleagues from the All Wales Medicines Strategy Group (AWMSG) and the All Wales Therapeutics and Toxicology Centre (AWTTC).
Our Director for Wales, Rick Greville talks about how ABPI Cymru Wales has been contributing to the assessment of the Welsh public’s opinion on healthcare delivery, and the how the discovery and access to innovative medicines impacts on patients’ lives.